Şebnem ÇALIK, İsmail DEMİR, Özden YILDIRIM AKAN, Selin YALINÇ, Oktay BİLGİR

COVID-19 TANISI ALMIŞ İLERİ YAŞTAKİ HASTALARIN KLİNİK ÖZELLİKLERİ VE İZLEM SONUÇLARI

Giriş: Bu çalışmanın amacı COVID-19 tanısı ile izlenen hastaların demografik ve laboratuvar özelliklerinitanımlamak ve COVID-19 tanısı konulmuş ileri yaştaki hastalarda mortalite ile ilişkili faktörleri değerlendirmektir.Gereç ve Yöntem: Bu çalışmaya 13 Mart 2020 - 10 Mayıs 2020 tarihleri arasında bir eğitim ve araştırmahastanesinde doğrulanmış COVID-19 tanısı ile yatarak izlenmiş hastalar dahil edilmiştir. Hastalara ait klinik bulgular,laboratuvar parametreleri, akciğer bilgisayarlı tomografisi bulguları, antiviral tedavi verilmesi ve solunum desteğiihtiyacı, sağ kalım durumu kaydedilmiştir. Verilerin analizinde kategorik değişkenler oran ve yüzdeler olaraktanımlanmıştır. Sürekli değişkenler ortalama, medyan değerleri kullanılarak tanımlanmıştır. İleri yaştaki hastalarınsağ kalım durumunu etkileyen faktörleri analiz etmek için forwardstepwise lojistik regresyon analizi yapılmıştır.Bulgular: Hastaların yaş ortalaması 55.7419.15 (18-96 yıl) olup, 67’si (% 41.9) 60 yaş ve üzerindedir. 60 yaşınaltındaki hastalarla karşılaştırıldığında, ileri yaştaki grupta hipertansiyon, konjestif kalp yetmezliği, diyabetesmellitus, KOAH, serebrovasküler hastalık ve demans gibi kronik hastalıklara da sık rastlanmaktadır (tümüp

CLINICAL FEATURES AND OUTCOMES OF ELDERLY PATIENTS DIAGNOSED WITH COVID-19

Introduction: The aim of this study is to represent the demographic features and laboratory findings of elderly patients diagnosed with COVID-19 and evaluate the factors associated with mortality. Material and Method: This study includes the patients who were hospitalized with a confirmed diagnosis of COVID-19 in a training and research hospital between 13 March 2020 and 10 May 2020. Clinical features, İzmir Eğitim ve Araştırma Hastanesi Tıp Dergisi (Medical Journal of İzmir Hospital) 25 (2): 115-121, 2021 116 İzmir Eğitim ve Araştırma Hastanesi Tıp Dergisi (Medical Journal of İzmir Hospital) laboratory parameters, chest CT findings, antiviral therapy, requirement of mechanical ventilation and survival status were collected. In the analysis of the data, categorical variables were defined as ratios and percentages. Continuous variables were defined by mean, median values. Forward stepwise logistic regression analysis was performed to analyze the factors associated with the survival status of elderly patients. Results:The mean age was 55.7419.15 (18-96 years) and 67 of all patients (% 41.9) were aged 60 and over. Chronic diseases such as hypertension, congestive heart failure, diabetes mellitus, COPD, cerebrovascular disease and dementia was common in elderly group, compared with patients under age of 60. (all p

PDF

___

1. Zhu N, Zhang D, Wang W, Li X, Yang B, Song J et al. A novel coronavirus from patients with pneumonia in China, 2019. N Engl J Med 2020; 382(8): 727-33.
2. Lu R, Zhao X, Li J,NiuP,Yang B, Wu H et al. Genomic characterisation and epidemiology of 2019 nove lcoronavirus: implications for virus origins and receptor binding. Lancet 2020; 395 (10224): 565–74.
3. Holshue ML, DeBolt C, Lindquist S, Lofy KH, Wiesman J, Bruce H et al. First case of 2019 novel coronavirus in the United States. N Engl J Med 2020; 382(10): 929-36.
4. Li Q, Guan X, Wu P,Wang X, Zhou L, Tong Y et al. Early transmission dynamics in Wuhan, China, of novel coronavirusinfected pneumonia. N Engl J Med 2020; 382(13): 1199-207.
5. Tong ZD, Tang A, Li KF, Li P, Wang HL, Yi JP et al. Potential presymptomatic transmission of SARS- CoV-2, Zhejiangprovince, China, 2020. Emerg Infect Dis 2020; 26(5): 1052-4.
6. Yu P, Zhu J, Zhang Z, Han Y. A familial cluster of infection associated with the 2019 novel coronavirus indicating potential person-to-person transmission during the incubation period. J InfectDis 2020; 221(11): 1757-61.
7. Huang C, Wang Y, Li X, Ren L, Zhao J, Hu Y et al. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet 2020; 395(10223): 497–506.
8. Liu K, Fang YY, Deng Y, Liu W, Wang MF, Ma JP et al. Clinical characteristics of novel coronaviruscases in tertiary hospitals in Hubei province. Chin Med J (Engl) 2020; 133(9): 1025-31.
9. Chen N, Zhou M, Dong X,Qu J, Gong F, Han Y et al. Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study. Lancet 2020; 395(10223): 507–13.
10. Wang D, Hu B, Hu C, Zhu F, Liu X, Zhang J et al. Clinical characteristics of 138 hospitalized patients with 2019 novel coronavirus-infected pneumonia in Wuhan, China. JAMA 2020; 323(11): 1061-69.
11. Yang X, Yu Y, Xu J,Shu H, Xia J, Liu H et al. Clinical course and outcomes of critically ill patients with SARS-CoV-2 pneumonia in Wuhan, China: a single-centered, retrospective, observational study. Lance tRespir Med 2020; 8(5): 475–81.
12. Republic of Turkey Ministry of Health, Guide of Covid-19 accessed at: 01.04.2021 https://covid19.saglik.gov.tr/TR66926/eriskin-hasta-tedavisi.html
13. Kim KH, Tandi TE, Choi JW, Moon JM, Kim MS. Middle East respiratory syndrome coronavirus (MERS-CoV) outbreak in South Korea, 2015: epidemiology, characteristics and public health implications. J Hosp Infect 2017; 95(2): 207-13.
14. Wang L, He W, Yu X, Hu D, Bao M, Liu H et al. Coronavirus disease 2019 in elderly patients: characterisitcs and prognostic factors based on 4-week follow-up. J Infect 2020; 80(6): 639-45. Cilt 25, Sayı 2, Nisan-Mayıs-Haziran; 2021 121
15. Lian J, Jin X, Hao S,Cai H, Zhang S, Zheng L et al. Analysis of epidemological and clinica lfeatures in older patients with coronavirus diseases 2019 (Covid-19) out of Wuhan. Clin Infect Dis 2020; 71(15): 740-7.
16. Chen TL, Dai Z, Mo P,Li X, Ma Z, Song S et al. Clinical characteristics and outcomes of older patients with coronavirus diseases 2019 (COVID-19) in Wuhan, China: A single-centered, retrospective study. J Gerontol A Biol Sci Med Sci 2020; 75(9): 1788-95.
17. Liu K, Chen Y, Lin R, Han K. Clinical features of Covid-19 in elderly patients. A comparison with young and middlaged patients. J Infect 2020; 80(6):e14-e18.
18. Tural Onur S, Altın S, Sokucu SN, İleri Fikri B, Barça T, Bolat E et al. Could ferritin level be an indicator of Covid-19 disease mortality? J Med Virol. 2021;93(3): 1672-7.
19. Connelly KG, Moss M, Parsons PE, Moore EE, Moore FA, Giclas PC et al. Serum ferritin as a predictor of the acute respiratory distress syndrome. Am J Respir Crit Care Med. 1997; 155(1): 21-5.
20. Wu C, Chen X, Cai Y, Xia J, Zhou X, Xu S et al. Risk factors associated with acute respiratory distress syndrome and death in patients with coronavirus Disease 2019 Pneumonia in Wuhan, China. JAMA Intern Med 2020; 180(7): 934-43.